Cargando…

Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics

The human small intestine can be involved in the first-pass metabolism of drugs. Under this condition, members of the CYP450 superfamily are expected to contribute to drug presystemic biotransformation. The aim of this study was to quantify protein expression levels of 16 major CYP450 isoforms in ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grangeon, Alexia, Clermont, Valérie, Barama, Azemi, Gaudette, Fleur, Turgeon, Jacques, Michaud, Veronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657875/ https://www.ncbi.nlm.nih.gov/pubmed/34884595 http://dx.doi.org/10.3390/ijms222312791

Ejemplares similares

Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
por: Michaud, Veronique, et al.
Publicado: (2010)

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study
por: Gravel, Sophie, et al.
Publicado: (2018)

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
por: Deodhar, Malavika, et al.
Publicado: (2020)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity
por: Darakjian, Lucy, et al.
Publicado: (2021)

Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues
por: Maximos, Sarah, et al.
Publicado: (2017)

Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
por: Deodhar, Malavika, et al.
Publicado: (2021)

Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics Are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia
por: Matos, Adriana, et al.
Publicado: (2020)

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition
por: Long, Tao, et al.
Publicado: (2021)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Current Status and Advances in Quantitative Proteomic Mass Spectrometry
por: Wasinger, Valerie C., et al.
Publicado: (2013)

Phylogenetic analysis of the cytochrome P450 (CYP450) nucleotide sequences of the horse and predicted CYP450s of the white rhinoceros (Ceratotherium simum) and other mammalian species
por: Leiberich, Marion, et al.
Publicado: (2018)

Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020)

Applications of CYP450 Testing in the Clinical Setting
por: Samer, C. F., et al.
Publicado: (2013)

The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021)

Role of Cytochrome P450 (CYP)1A in Hyperoxic Lung Injury: Analysis of the Transcriptome and Proteome
por: Lingappan, Krithika, et al.
Publicado: (2017)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

mspire: mass spectrometry proteomics in Ruby
por: Prince, John T., et al.
Publicado: (2008)

Computational Mass Spectrometry–Based Proteomics
por: Käll, Lukas, et al.
Publicado: (2011)

Comparing cellular proteomes by mass spectrometry
por: Fröhlich, Florian, et al.
Publicado: (2009)

Urine Proteomics in the Era of Mass Spectrometry
por: Beasley-Green, Ashley
Publicado: (2016)

Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs
por: Michaud, Veronique, et al.
Publicado: (2021)

Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells
por: Leung, Yat Hei, et al.
Publicado: (2017)

CYP450 core involvement in multiple resistance strains of Aedes aegypti from French Guiana highlighted by proteomics, molecular and biochemical studies
por: Epelboin, Yanouk, et al.
Publicado: (2021)

Identification and analysis of CYP450 genes from transcriptome of Lonicera japonica and expression analysis of chlorogenic acid biosynthesis related CYP450s
por: Qi, Xiwu, et al.
Publicado: (2017)

Effect of codeine on CYP450 isoform activity of rats
por: Wang, Shuanghu, et al.
Publicado: (2017)

Compound Shuganjieyu Capsule on CYP450 Enzyme Activity
por: Tang, Yunqiu, et al.
Publicado: (2022)

Proteomic Analysis and Discovery Using Affinity Proteomics and Mass Spectrometry
por: Olsson, Niclas, et al.
Publicado: (2011)

CYP2C9, a Metabolic CYP450s Enzyme, Plays Critical Roles in Activating Ellagic Acid in Human Intestinal Epithelial Cells
por: Gu, Yang, et al.
Publicado: (2020)

Transcriptome Analysis of CYP450 Family Members in Fritillaria cirrhosa D. Don and Profiling of Key CYP450s Related to Isosteroidal Alkaloid Biosynthesis
por: Li, Rui, et al.
Publicado: (2023)

CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine
por: Pybus, Brandon S, et al.
Publicado: (2012)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Mass spectrometry–based proteomics in cell biology
por: Walther, Tobias C., et al.
Publicado: (2010)

Proteomics and mass spectrometry in the diagnosis of renal amyloidosis
por: Picken, Maria M.
Publicado: (2015)

Web Resources for Mass Spectrometry-based Proteomics
por: Chen, Tao, et al.
Publicado: (2015)

Heart Disease, Clinical Proteomics and Mass Spectrometry
por: Stanley, Brian A., et al.
Publicado: (2004)

Mass spectrometry-based draft of the mouse proteome
por: Giansanti, Piero, et al.
Publicado: (2022)

Beyond mass spectrometry, the next step in proteomics
por: Timp, Winston, et al.
Publicado: (2020)

Emergence of mass spectrometry detergents for membrane proteomics
por: Behnke, Jan-Simon, et al.
Publicado: (2023)

Characterizing citrullination by mass spectrometry-based proteomics
por: Rebak, A. S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gm2c1ps41182p0ipu1fm1q93fk